Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Myasthenia Gravis
Pharma
J&J's Imaavy comes up short in rheumatoid arthritis study
Flying high after an FDA approval to treat gMG, J&J's Imaavy has come up short as part of a combination therapy in a rheumatoid arthritis trial.
Kevin Dunleavy
Aug 29, 2025 10:56am
Argenx pursues Vyvgart nod in seronegative myasthenia gravis
Aug 25, 2025 11:38am
Argenx serves up Seles collab for myasthenia gravis awareness
Aug 12, 2025 7:00am
AZ's Alexion spotlights gMG for next awareness-raising film
Jul 31, 2025 12:42pm
Vor Bio's surprise $4B revival deal splits investor reactions
Jun 26, 2025 10:55am
Argenx brews up ad for Vyvgart Hytrulo prefilled syringe in gMG
May 8, 2025 2:31pm
